Stemtech (STEK) Common Equity (2012 - 2025)

Stemtech has disclosed Common Equity across 14 years of filings, most recently posting -$7.7 million for Q4 2025.

• Common Equity for Q4 2025 came in at -$7.7 million, down 47.4% year-over-year; the trailing twelve-month figure through Dec 2025 was -$7.7 million (down 47.4% YoY), and the FY2025 annual result was -$7.7 million, down 47.4% from the prior year.
• Common Equity came in at -$7.7 million for Q4 2025 at Stemtech, down from -$6.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $896097.0 in Q1 2021 to a low of -$28.8 million in Q2 2022.
• The 5-year median for Common Equity is -$4.6 million (2022), against an average of -$5.4 million.
• Across the five-year window, Common Equity tumbled 11505.16% in 2022 and soared 87.17% in 2023, its largest moves.
• Stemtech's Common Equity stood at -$4.0 million in 2021, then increased by 20.81% to -$3.2 million in 2022, then advanced by 12.39% to -$2.8 million in 2023, then plunged by 88.1% to -$5.2 million in 2024, then sank by 47.4% to -$7.7 million in 2025.
• The last three Common Equity figures came in at -$7.7 million (Q4 2025), -$6.5 million (Q3 2025), and -$6.5 million (Q2 2025), per Business Quant data.